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Presence of the terminal attack complex of complement in glomerular
deposits in rats with Heymann nephritis (HN) coincides with the devel-
opment of proteinuria. E. de Heer, M. R. Daha, and L. A. van Es. De-
partment of Nephrology, University Hospital, Leiden, The Nether-
lands. We investigated whether the appearance of various comple-
ment components in renal deposits of immune complexes correlated
with the development of proteinuria in rats with active HN. Sequen-
tial kidney biopsies and serum samples were obtained from Lewis rats
immunized with Fx1A in CFA. Circulating auto-antibodies against
purified auto-antigen (RTE-Gp) were measured by ELISA. A gradual
appearance and persistence of Clq, C3, C4, and factor H was demon-
strated in glomerular deposits by immunofluorescence using monospe-
cific antisera against rat complement components. Factor B was pres-
ent temporarily and in minimal amounts, indicating that the activation
of complement in active HN occurs by the classical pathway. The ap-
pearance of the membrane attack complex of complement (C5b-C9) in
glomerular deposits coincided with the development of abnormal pro-
teinuria indicating that the glomerular damage in this autoimmune dis-
ease is caused by complement-mediated lesions in the glomerular cap-
illary walls.
Use of cyclosporin A (CIA) only after cadaveric renal transplantation:
Renal function studies during conversion to prednisolone (P) and azathi-
oprine (A) 4 months after transplantation. A. Tegzess, A. Donker, S.
Mejer, W. van Son, F. van der Woude, M. Slooff, G. van der Hem,
L. van der Slikke, W. Sluiter, and V. Fidler. Department of Nephrol-
ogy, University Hospital, Groningen, The Netherlands. One of the ma-
jor side effects of CIA is nephrotoxicity. The longterm effect of this
drug on the graft function is not clear. Therefore, it was decided to con-
vert the cadaveric transplant recipients (CTR) from CIA to P and A, 4
months after transplantation. Forty-one CTR were treated with CIA
exclusively. Rejection episodes (R) were diagnosed on clinical grounds
and ultrasonography. R were treated with three times 1 g iv. of Solu-
Medrox per R. If more than three R occurred, the CTR were con-
verted before the fourth postoperative month to P and A (N = 19).
Two CTR were kept on CIA treatment. Elective conversion of the re-
maining 20 CTR was carried out by adding 10 mg of P b.i.d. during 1
week together with CIA. Thereafter, CIA was replaced by A 1.5 mg/kg
body weight, while 20 mg P was continued. Effective renal plasma flow
(ERPF) and glomerular filtration rate (GFR) were measured just be-
fore administration of P, 1 week later, 1 week after cessation of CIA
and finally, 6 weeks later. ERPF and GFR were determined by simul-
taneous, continuous infusion of °'I-hippurate and '251-thalamate, re-
spectively. Before conversion mean ERPF and GFR were the same in
CTR with (N = 14) or without R (N = 6). After I week of P together
with CIA, GFR improved in all CTR. In contrast ERPF improved only
in CTR without previous R (P < 0.05). One week after replacement of
CIA by A, improvement of ERPF and GFR occurred in all CTR. From
these results it is concluded that before adding P to CIA treatment a
low grade rejection, reversible by steroids, existed as a partial cause
of renal function abnormality 4 months after transplantation. No kid-
neys were lost after conversion.
Prevention of acute tubular necrosis (ATN) in cadaveric renal trans-
plantation by the combined use of mannitol and moderate hydration. R.
G. W. L. Tiggeler, J. H. M. Berden, A. J. Hoitsma, and R. A. P.
Koene. Department of Nephrology, St. Radboudziekenhuis, Univer-
sity of Nmegen, The Netherlands. Recent studies indicate that maxi-
mal hydration of the transplant recipient can substantially reduce the
incidence of ATN. However, this policy requires invasive hemody-
namic monitoring, prolonged mechanical ventilation, and bears the risk
of overhydration. In a prospective trial we studied the incidence of
ATN in recipients of cadaveric kidneys after restricted fluid infusion
(group I, N = 21), after restricted fluid infusion along with 250 ml of
mannitol 20% (group 2, N = 19), and after moderate hydration to-
gether with 250 ml mannitol 20% (group 3, N = 21). Donor and pre-
operative recipient parameters were comparable in all three groups.
The total amount of fluid administered during operation and the inci-
dence of ATN were in group 1, 1059 371 ml and 43%; group 2, 1548
622 ml and 53%; and group 3, 2529 675 ml and 4.8%. Vasopres-
sive agents, furosemide, and albumin have not been used. Blood trans-
fusions were given only for substitution of a loss of more than 500 ml.
The moderate hydration policy in group 3 resulted in a significantly
higher peroperative systolic blood pressure compared to groups 1 and
2. Diastolic blood pressure peroperative was the same in the three
groups. Postoperative systolic and diastolic blood pressure was com-
parable in the three groups. We did not observe any problems related
to overhydration. The reduction of the ATN incidence led to a substan-
tial decrease in the number of postoperative hemodialysis treatments
(group 1: 21; group 2: 26; group 3: 1); radionuclide scans (respec-
tively, 19-16-0); ultrasound investigations (respectively, 5-1-0); trans-
plant biopsies (respectively, 6-5-0), and rejection episodes in the first 3
months (respectively, 15-12-1 1). It is concluded that moderate fluid ad-
ministration of 2.5 liters during the transplant procedure together with
infusion of 250 ml of mannitol 20% immediately before vessel clamp
release reduces the incidence of ATN below 5%. The procedure is
safe, simple, and does not require invasive hemodynamic monitoring.
Clinical experience with a closed volume hemodiafiltration apparatus.
J. A. van Geelen and J. A. Flendrig. Department of Internal Medicine
I, University Hospital D(ikzigt, Rotterdam, The Netherlands. Hemodi-
afiltration (HDF) with a dialysate flow (Qd) of 100 ml/min and an ul-
trafiltration flow (Q) of 60 mI/mm was performed using a double-closed
circuit consisting of 20 liter dialysate and 10 liter substitution fluid
bags, placed in liquid-filled, airtight closed containers. This system al-
lows strict control of fluid balance. In six patients HDF at Qd = 100
mI/mm (3 x 3 1/2 hr/wk), was compared to conventional hemodialysis
(HD) at Qd = 500 ml/min (3 x 4 hr/wk). The blood flow (Qb) was kept
at 200 mI/mm. Only RP6 dialysers were used in both procedures. In
HD fluid balance was controlled by means of an isovolumetric pump
to achieve the same degree of accuracy as with HDF. In HDF fluid
withdrawal was better tolerated than in HD. Symptomatic hypoten-
sive episodes were observed in ten out of 50 HD sessions as compared
to only one out of 50 HDF sessions. The improved treatment toler-
ance could not be ascribed to differences in acetate load, correction of
acidosis, baroreceptor function, blood temperature, or accuracy of
fluid balance control. The only difference between both procedures
was a slightly less negative sodium balance in HDF and a somewhat
lower small solute clearance in HDF, resulting in a mean osmolality
drop of 15 mOsm/kg in HDF as compared to 30 mOsm/kg in HD. How-
ever, these differences were not felt to be of sufficient magnitude to ex-
plain the difference in blood pressure behavior. Extensive mass bal-
ance studies in HDF indicated that adequate blood purification with
regard to both small and middle molecular solutes is obtained by rela-
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tively small volumes of dialysate and substitution fluid. Adequate dif-
fusive mass transport is maintained at a lower limit of °d 150
mi/mm. At an upper limit of O = 60 mI/mm transmembrane pressure
does not exceed 400 mm Hg. Thus, safety, simplicity, and cost reduc-
tion may favor the use of HDF on a routine basis in selected patients.
Urinary excretion of free hydroxylysyiglycosides in healthy children
and adults, and in patients suffering from Alport syndrome. C. H.
SchrOder, L. A. H. Monnens, J. P. M. Langeveld, J. M. F. Tri:jbels,
and J. H. Veerkamp. Departments of Pediatrics and Biochemistry,
University of Nzjmegen, Njmegen, The Netherlands. The glycosides
of hydroxylysine, glucosylgalactosylhydroxylysine (GGH), and galac-
tosylhydroxylysine (GH) are specific markers for basement membrane
collagen. For Alport- syndrome, a molecular disturbance of basement
membrane collagen is. assumed. Increased excretion of free hydroxy-
lysyiglycosides has been reported in patients suffering from Alport syn-
drome. Therefore, after purification of urine using a cation-exchange
resin, aminotacid-analysis of the basic amino-acid fraction was per-
formed. Urinary specimens of 12 healthy adults and 28 healthy chil-
dren, as well as of 11 adult patients and 11 children suffering from
Alport synthome were investigated. No significant differences in ex-
cretion rates of GGH and GH between healthy persons and patients
could be detected. GGH/GH-ratio and percentage glycosylated
hydroxylysine also were in the normal range. We were not able to con-
firm the data reported in the literature. Theoretically, investigation of
urinary excretion of peptide-bound hydroxylysylglycosides might be a
more promising approach.
Percutaneous transluminal renal angioplasty (PTRA): Effects on renal
function. T. K. Kremer Hovinga, P. E. de Jong, D. de Zeeuw, A. J.
M. Donker, and G. K. van der Hem. Department of Nephrology, State
University Hospital, Groningen, The Netherlands. Improvement of an
impaired effective renal plasma flow (ERPF) and glomerular filtration
rate (GFR) after PTRA has been described. These studies often are dif-
ficult to interpret, due to concomitant changes in medication. We there-
fore studied renal function shortly before and within 2 weeks after
PTRA in 13 hypertensive patients with a unilateral renal artery steno-
sis. On the angiograms an atherosclerotic type of stenosis was diag-
nosed in ten of the patients, while the other three showed a fibromus-
cular dysplasia type of stenosis. In four patients the contralateral ar-
tery was occluded. Five patients had no antihypertensive medication
and eight patients used the same medication at least 2 weeks before and
1 week after PTRA. In all patients with a contralateral occlusion ERPF
(initially 157 107 mi/mm) increased 14 3%. GFR (43 31 ml/min)
however, did not change and thus FF fell. In the nine patients with a
patent contralateral artery ERPF (293 98 mI/mm) increased simi-
larly (15 14%; P < 0.02). In this group GFR (72 22 mI/mm) also
did not change significantly. In the overall group (N = 13) the greatest
fall in FF was observed in the subjects with the more impaired GFR (r
= 0.61; P < 0.05). Interestingly, a more than 10% increase in ERPF(N = 10) was only followed by a more than 10% rise in GFR in four
patients who had a modest impairment in GFR before the procedure
(86 7 ml/min). In conclusion, the improved renal blood flow after
PTRA results only in a rise in GFR in those subjects with a modest
impairment of GFR. In the others (both the patients with contralateral
occlusion and those with a patent contralateral artery but with a more
pronounced impairment in GFR) the improved flow is not transfered
to a better filtration.
Adrenergic activity and peripheral hemodynamics in relation to so-
dium sensitivity in patients with essential hypertension. M. I. Koolen and
P. van Brummelen. Department of Nephrology, University Hospital,
Leiden, The Netherlands. The aim of the study was to determine the
relevance of clinical, adrenergic, and hemodynamic variables for the
inter-individual differences in blood pressure response to changes in di-
etary sodium intake observed in patients with essential hypertension
(EH). Twenty-five patients (all Caucasians, 15 males and 10 females)
with a mean age of 41.3 years (range, 22 to 61 years) participated in
this outpatient study. After a 4-week control period of regular sodium
intake, the patients were studied on two different levels of sodium in-
take, 50 and 300 mmoles, respectively, for 2 weeks. The sequence of
these diets was randomly assigned. Mean arterial pressure (MAP) and
body weight (BW) were measured at the end of the study periods as
were plasma norepinephrine (PNE) and norepinephrine release. The
24-hr urinary sodium excretion (UNa) was also determined. Basal fore-
arm blood flow (FAF) was measured by plethysmography and forearm
vascular resistance was calculated. Norepinephrine release was deter-
mined by constant infusion of L-norepinephrine. UN. was 62.2 6.2
(means sEM) at the end of the low sodium (LS) period and 271.0
15.8 mmoles/24 hr at the end of the high sodium (HS) period. In the
individual patients the difference in MAP between HS and LS (A MAP)
ranged from + 18 to —8 mm Hg (mean, 5.2 mm Hg) and this was used
as a measure of sodium sensitivity. The eight patients in whom A MAP
was greater than 10 mm Hg were regarded as salt-sensitive. A MAP
correlated with age (r = 0.42, P < 0.05) and initial MAP (r = 0.50, P
< 0.01) but not with A BW (r = 0.28). A MAP correlated with PNE
during HS (r = 0.56, P < 0.01) and with A PNE (between HS and LS)
r = 0.58, P < 0.01. A MAP was correlated with A norepinephrine re-
lease (r = 0.46, P < 0.02). A MAP was directly related to A FVR (r =
0.51) and inversely related to A FAF (r = —0.46, P < 0.02). When
compared with salt-insensitives, salt-sensitive patients had a higher ini-
tial blood pressure (P < 0.05) and higher PNE levels in they êontrol pe-
riod (P < 0.05) and at the end of HS (P < 0.01). It is concluded that
sodium sensitivity is related to age and blood pressure level. It is pre-
dominantly mediated by changes in vascular resistance to which the
adrenergic nervous system is likely to contribute.
Urinary excretion of prostaglandins in healthy volunteers (HV) and pa-
tients with essential hypertension (EH): Influence of seminal fluid con-
tamination. P. Koopmans, C. Thomas, R. v. d. Berg, T. Thien, and F.
Gribnau. Department of Medicine, Division of General Internal Medi-
cine and Laboratory of Obstetics and Gynecology. Radboudhospilal
Nijmegen, The Netherlands. In this study the 24-hr urinary excretions
of prostaglandins (PGs) E2, F2,,, 6-Keto-PGF1,,, and thromboxane B2(TxB2) were measured by radioimmunoassay in one male and one fe-
male HV during 16 and 11 consecutive days, respectively. Days upon
which both volunteers had sexual intercourse were recorded. Subse-
quently, PGs were measured in two 24-hr urine samples from 27 HV
[13 males, mean age 38 9 (SD); 14 females, mean age 32 9 years}
and 41 untreated patients with EH (19 males, mean age 43 13 years;
22 females, mean age 41 14 years). Results include: longitudinal
measurements of urinary PGs excretions in the 2 HV, revealed a dra-
matic increase of all PGs (TxB2 except), and of the ratio PGE2/PGF2,,
to values greater than 0.5, on days with sexual intercourse, in both
sexes. The table gives the PGs excretion in the groups of HV (N =
26) and patients with EH (N = 40) after exclusion of the samples with
a PGE2/PGF2,, ratio greater than 0.5 (N = 2).
Male Female
HV EH HV EH
PGE2
PGF2,,
6KPGF1,,
TxB2
1.5 1.0
15.0 4.8
7.5 5.3
2.5 1.0
1.2 1.2
11.6 6.4
10.5 6.2
2.4 1.0
0.3
6.1
6.2
1.3
0.2a
1.2
1.4
0.3a
0.3 0.2
6.5 l.9
7.2 2.5a
2.2 11b
Values are in nmoles/24 hr, as means sn.
a P < 0.01 (between sexes).
b P < 0.05 (between groups) (Student t test for unpaired data).
In conclusion, (1) the PGE2/PGF2,, ratio can be used as an index for
seminal fluid contamination. (2) Males have higher urinary excretions
of PGE2 and PGF2,, than females. (3) With the exception of a higher
TxB2 excretion in female patients with EH, no differences can be dem-
onstrated in excretions of PUs between HV and patients with EH.
Renal function and blood pressure after kidney transplantation in the
rat. A. P. Provoost, M. H. de Ke(/zer, E. D. Wolff, and J. C. Molen-
aar. Department of Pediatric Surgery and Pediatrics, Erasmus Uni-
versity Rotterdam, The Netherlands. After isogeneic kidney transplan-
tation within an inbred rat strain (WAG), systolic blood pressure (SBP)
remained normal and the glomerular filtration rate (GFR) was about
80% of that of unilaterally nephrectomized control rats. After alloge-
neic kidney transplantation from BN donors into WAG recipients, with
allograft survival prolonged by pretreatment with donor strain blood
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(DSB), hypertension developed during week 2 after transplantation.
This hypertension (SBP 175 mm Hg in recipients vs. 130 mm Hg in
control rats) was associated with a reduced GFR and a low plasma
renin concentration (PRC). The reduced GFR indicates that preven-
tion of rejection by pretreatment with DSB only was incomplete. The
low PRC may indicate that sodium retention was involved in the rise
in SBP. These hypotheses were further investigated. The role of an in-
complete prevention of rejection was investigated by the use of addi-
tional immunosuppression. A short course of cyclosporin A (CsA) was
given in a dose of 15 mg/kg i.m. on days 0, 4, and 7 after transplan-
tation. Either alone or in combination with DSB, the use of CsA re-
sulted in normotensive recipients. The recipients treated with CsA had
a higher GFR than observed in recipients pretreated with DSB only,
indicating that a better immunosuppression was achieved. The role of
sodium in the development of hypertension was investigated by reduc-
ing the intake of sodium after allogeneic kidney transplantation in DSB-
pretreated recipients. A reduction of the sodium intake to less than
15% of the control recipients prevented the rise in SBP and caused an
increase in PRC. From these studies we conclude that, in this rat model
of postrenal transplantation hypertension, the rise in SBP is the result
of sodium retention due to structural and/or functional changes within
the allograft caused by an incomplete prevention of the rejection
process.
Decreased ATPase activity in the glomerular basement membrane
(GBM) of rats with experimental nephrotic syndrome: Cytochemical
demonstration at the ultrastructural level. W. W. Bakker, C. E. Hal-
staert, D. Kalichuran, and M. J. Hardonk. Department of Pathology
and Center for Medical Electron Microscopy, University of Gronin-
gen, Groningen, The Netherlands. Although much is known about the
molecular organization of the glomerular basement membrane (GBM)
of the rat, the presence of phosphatases in this extracellular structure
is only recently described. In this study we have compared the in situ
activity of Mg -dependent nucleoside polyphosphatase (ATPase) in
the GBM of nephrotic and control rats. Female PVG/c rats (3 months
of age) were rendered nephrotic by a single intravenous injection of
Adriamycin (6 mg/kg body wt) and proteinuria of diseased and control
(saline-injected) rats was measured using the biuret method. After 3
weeks kidneys from proteinuric (200 to 250 mg/24 hr) or control ani-
mals were perfused in vivo under ether anesthesia for 5 mm with 2%
glutaraldehyde and subsequently processed for demonstration of
ATPase using the cerium-based method. The results show that the
amount of reaction product in the GBM of nephrotic animals was con-
siderably reduced whereas staining of epithelial plasma membranes ap-
peared unchanged as compared with kidneys from control animals. As
expected, the effacement of the epithelial podocytes along the GBM in
the proteinuric animals was clearly visible. Since Adriamycin is toxic
for the epithelial cells, shedding or excretion of enzyme molecules
toward the GBM may be disturbed. This might result in a gradual dis-
appearance of enzyme molecules from the GBM. The decrease of
GBM ATPase activity contrasts with the unchanged existence of an-
ionic sites in this model. The question remains whether this reduced
phosphatase activity in the GBM plays a role in the pathogenesis of in-
creased glomerular permeability in this experimental model.
Nephropathy in systemic amyloidosis: Characteristics at the time of re-
nal biopsy. S. Janssen, S. Meijer, M. H. van Rijswijk, G. K. van der
Hem, and E. Mandema. Department of Medicine, University Hospi-
tal, Groningen, The Netherlands. Nephropathy is a major problem in
both AA and AL amyloidosis. In 53 patients with amyloidosis we per-
formed a renal biopsy, 50 of which showed amyloid. In three patients
with rheumatoid arthritis and a positive rectal biopsy, the renal biopsy
showed lesions attributable to the disease per se or to penicillamine.
In 41 patients the renal amyloid deposits were potassium permangan-
ate sensitive (AA); nine patients had potassium permanganate resist-
ant amyloid deposits (AL). Involvement of the heart, the nervous sys-
tem, and the tongue was seen only in the AL group. No amyloid could
be demonstrated in the rectal biopsies of eight patients in the AA group
and two patients in the AL group. There were no bleeding problems
attributable to biopsy procedures. Abnormalities of coagulation tests
(bleeding time, prothrombin time, activated partial thromboplastin
time, and antithrombin III) were uncommon. In one patient the acti-
vated partial thromboplastin time was prolonged due to factor IX and
XII deficiency, caused by the nephrotic syndrome. Hypertension was
found in 22% (diastolic blood pressure > 90 mm Hg). Hematuria ( 5
red cells per high power field) was found in 12% of the patients. There
was no difference in creatinine clearance between the AA (median, 45
mI/mm; range, < 5 to 175 mI/mm) and the AL group (median, 50
mi/mm; range, 12 to 106 ml/min) at the time of renal biopsy. Protein-
uria was more massive in the AL (median, 9 g/24 hr; range, 0.5 to 22
g/24 hr) than in the AA group (median, 6 g/24 hr; range, 0.5 to 20 g/24
hr) (P < 0.02); nephrotic syndrome (proteinuria  5 g/24 hr) was pres-
ent in 89% of the former and in 59% of the latter. Whereas there is no
correlation between the degree of proteinuria and the creatinine clear-
ance, there appears to be a negative correlation between the selectiv-
ity index of the proteinuria and the creatinine clearance (r = — 0.625,
P < 0.001). In 14 out of 30 AA patients and in 4 of 8 AL patients the
proteinuria was selective at the time of renal biopsy. Enlarged kidneys
were rare; contracted kidneys were a regular finding, particularly in ad-
vanced renal failure. There is a weak positive correlation between kid-
ney size and creatinine clearance (r = 0.356, P < 0.02). Renal tubular
function studies in amyloidosis are not available on any large scale in
literature. In our series of patients a significant increase in the relative
clearance of ssmTcdimercaptosuccinate (DMSA), representing a dis-
turbance of proximal tubular function, was found in 88% of the pa-
tients. There appeared to exist a strong negative correlation between
the relative clearance of mTcDMSA and renal function, measured by
the GFR (r =
—0.719, P < 0.001).
Effect of captopril on split renal function in unilateral renal artery ste-
nosis. G. J. Wenting, H. L. Tan Thong, F. H. M. Derkx, A. J. Man in
't Veld, and M. A. D. H. Schalekamp. Department of Internal Medi-
cine I, University Hospital Dijkzigt, Rotterdam, The Netherlands. Re-
cent evidence indicates that the administration of captopril to patients
with either bilateral renal artery stenosis or a stenosis affecting a soli-
tary functioning kidney can result in deterioration of kidney function.
It was proposed that captopril interferes in the delicate balance be-
tween pressure and flow required for optimal regulation of glomerular
filtration in these patients. In unilateral disease such an effect may eas-
ily go unnoticed because of the functional reserve of the opposite kid-
ney. We, therefore, have measured the renal extraction ratios of 131I
sodium iodohippurate (EH) and '251-thalamate (ET) before and 60 mm
after captopril, 50 mg, in 14 patients with an unilateral renal artery ste-
nosis and in 17 patients with essential hypertension. EH and ET were
greatly reduced on the affected side by captopril in seven out of the 14
patients with a stenosis. The reduced EH probably reflected a short-
ened plasma transit time through the kidney due to intrarenal vasodil-
atation. The reduced ET reflected a low filtration fraction, suggesting
that the vasodilatation was, at least in part, at the level of the postglo-
merular arterioles. With longterm captopril, 150 mg daily, the uptake
of ssmTcdiethylenetriaminepentaacetic acid by the affected kidney,
which was determined by scintillation camera renography, became al-
most zero in these seven patients indicating severe reduction of the
glomerular filtration rate. Captopril had little effect on the contralat-
eral kidney and on the kidneys of the patients with essential hyper-
tension; serum creatinine concentrations showed minor changes. Func-
tion of the affected kidney returned on discontinuing captopril. We ad-
vise to perform radioisotope renography after initiation of captopril in
patients who have renal artery disease or are suspected to have this
disease. In the latter, finding seriously impaired function on one side
during captopril may be diagnostic. When the split renal uptake of the
isotope falls, it would be prudent to stop captopril because the conse-
quences of long-lasting impairment of glomerular filtration are un-
known.
Renal function changes during treatment with cis-platin. J. J. G. Of-
ferman, S. Me(/er, D. T. Sleijfer, N. H. Molder, A. J. M. Donker, H.
Schraffordt Koops, and G. K. van der Hem. Departments of Nephrol-
ogy and Oncology, University Hospital, Groningen, The Netherlands.
Eleven patients were treated with a cis-diammino-dichloroplatinum
(CDDP) containing combination chemotherapy regimen for dissemi-
nated testicular cancer. Renal function studies were performed on days
1, 10, and 21 of the first course of chemotherapy and at the end of treat-
ment, on the 10th day of the fourth course (day 73) because of the
known nephrotoxicity of CDDP. Renal function studies consisted of
measuring effective renal plasma flow (ERPF) and glomerular filtration
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rate (GFR) and calculating filtration fraction (FF = GFR/ERPF). GFR
and ERPF were measured with '251-sodium thalamate and 131j hippur-
ate, respectively, as the patients were in a supine position. On day 1,
during CDDP infusion, a consistent decrease in ERPF (P < 0.01) was
found, together with an increase in FF (P < 0.01). GFR did not change
significantly. These findings suggest primary changes in renal hemo-
dynamics. A possible explanation could be that CDDP, like mercuric
chloride, leads to an increase in prostaglandin synthesis in the
glomeruli, which leads to an increase in angiotensin 11 through stimu-
lation of glomerular cyclic AMP and renin. This angiotensin II in-
crease can lead to a decrease in ERPF. On day 10 ERPF was still de-
creased, but on this point GFR was also diminished (P < 0.01). The
filtration fraction had reversed to pretreatment values. The same trend
was found on day 21 (decreases in ERPF and GFR both did not differ
significantly from the values on day 10). This GFR decrease later on
during the treatment can be explained by a reduced driving force for
filtration through a reduced ERPF. Another explanation could be tu-
bular obstruction or tubular back leak; both possibilities are found in
experimental work with mercuric chloride. On day 73 further de-
creases in ERPF and GFR were observed leading to a median de-
crease of respectively 45 and 32% compared to the pretreatment val-
ues. ERPF and GFR on day 73 differed significantly (P < 0.01) com-
pared to day 21, pointing to cumulative toxicity. The acute, hemody-
namic effects of cis-platin might be mediated by the renin-angiotensin
system. For this reason we tried captopril, an angiotensin I converting
enzyme inhibitor, in another eleven CDDP-treated patients and found
during CDDP infusion on day I a smaller decrease in ERPF (P < 0.02).
It is tempting to relate the initial changes to the long-term effect of
CDDP on renal function. Prevention of these initial changes, that is, a
maintenance of ERPF with captopril, might prevent later renal func-
tion damage caused by CDDP and deserves further study.
Mesangial function and glomerular sclerosis in rats with aminonucle-
oside (PAN) nephrosis. J. Grond, J. Koudstaal, H. van Goor, and J.
D. Elema. Department of Pathology, University of Groningen, Gro-
ningen, The Netherlands. The possible relationship between mesan-
gial dysfunction and development of glomerular sclerosis was studied
in the chronic PAN model. In experiment A five male Wistar rats were
injected subcutaneously with 2 mg of PAN per 100 g body wt weekly
for 3 weeks and subsequently every other week. Five controls re-
ceived saline. After 4 weeks the PAN rats were severely proteinuric
(190 80 mg/24 hr) and all rats were given 30 mg of colloidal carbon
(CC) per 100 g body wt intravenously followed by 20 mg CC per 100 g
at weeks 5 and 6. At 5 months glomerular sclerosis was found in 7.6
3.4% of the glomeruli of PAN rats; glomeruli of controls were nor-
mal. Glomeruli of the PAN rats contained significantly more CC than
control glomeruli as measured semiquantitatively with a modular scan-
ning image analyzer. Glomeruli with sclerosis contained significantly
more CC than nonsclerotic glomeruli in the same kidneys. By light
microscopic examination CC was preferentially localized within the
sclerotic areas of the affected glomeruli. In experiment B PAN injec-
tions were started after CC administration to check mesangial CC
clearance during chronic PAN treatment. However, mesangial CC
clearance did not differ from that of saline-injected rats. Therefore, we
conclude that the preferential CC localization within the sclerotic ar-
eas in experiment A is caused by an increased CC uptake shortly after
injection in apparent vulnerable areas where sclerosis will develop sub-
sequently. In experiment C cluster analysis showed a random distri-
bution of lesions in PAN glomeruli in concordance with the random lo-
calization of mesangial areas with dysfunction in this model. Thus, al-
though the remnant kidney on the one hand and the chronic PAN
model on the other are clearly different with respect to many renal
functional features, they share development of glomerular sclerosis
possibly due to mesangial dysfunction as a common quality.
A heterologous model of murine-SLE induced by antibodies against
GP7O. G. J. Fleuren, S. 0. Warnaar, and P. J. Hoedemaeker. Depart-
ment of Pathology, University of Leiden, Leiden, The Netherlands. In
murine SLE a variety of auto-antibodies as well as immune complexes
can be found in the serum. Their role in the development of the asso-
ciated glomerulonephritis is not certain. In the present experiments we
established the role of antibodies against a retroviral glycoprotein
(gp7O) in the pathogenesis of murine SLE-associated glomerulonephri-
tis. Injection of heterologous anti-gp7O into normal Balb/c mice re-
sulted in an immediate binding to the glomerular basement membrane
(GBM) in a mixed granular and linear pattern. After 14 days a distinct
granular fluorescence was noted of both heterologous IgG and mice
IgG, associated with epimembranous aggregates in the GBM in elec-
tron microscopy. In Lewis, Wistar, and Brown-Norway rats an injec-
tion of the antibody resulted in an immediate clear linear binding to the
GBM. Injection of mice and rats with normal heterologous serum did
not result in a specific immunofluorescence pattern of IgG in the
glomeruli. The patterns in immunofluorescence microscopy suggest a
binding of antibodies to antigens which are present in the glomerular
capillary wall. It is concluded that antibodies to gp7O, which usually
occur in murine SLE, induced immune deposits in the glomeruli of nor-
mal mice and rats through binding to endogenous gp7O antigen ex-
pressed in the glomerular capillary wall.
